Ad is loading...
QKBGX
Price
$23.62
Change
-$0.17 (-0.71%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

QKBGX vs RLEFX

Header iconQKBGX vs RLEFX Comparison
Open Charts QKBGX vs RLEFXBanner chart's image
Federated Hermes MDT Balanced R6
Price$23.62
Change-$0.17 (-0.71%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
QKBGX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QKBGX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QKBGX is a StrongSell and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. QKBGX (245M). RLEFX pays higher dividends than QKBGX: RLEFX (2.42) vs QKBGX (1.72). QKBGX was incepted earlier than RLEFX: QKBGX (18 years) vs RLEFX (9 years). RLEFX is a more actively managed with annual turnover of: 171.00 vs. QKBGX (104.00). QKBGX has a lower initial minimum investment than RLEFX: QKBGX (0) vs RLEFX (250). QKBGX annual gain was more profitable for investors over the last year : 25.91 vs. RLEFX (21.09). RLEFX return over 5 years is better than : 35.95 vs. QKBGX (30.80).
QKBGXRLEFXQKBGX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years9 years-
Gain YTD17.68814.211124%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets245M236B0%
Annual Yield % from dividends1.722.4271%
Returns for 1 year25.9121.09123%
Returns for 3 years0.5710.955%
Returns for 5 years30.8035.9586%
Returns for 10 years57.57N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology